BarrettJS. Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms. Nutr Clin Pract. 2013;28:300-306.
2.
OngDKMitchellSBBarrettJS. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010;25:1366-1373.
3.
KaptchukTJFriedlanderEKelleyJM. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010;5:e15591.
4.
StaudacherHMLomerMCAndersonJL. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012;142:1510-1518.
5.
KaptchukTJKelleyJMConboyLA. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ. 2008;336:999-1003.
6.
ConboyLAMacklinEKelleyJKokkotouELemboAKaptchukT. Which patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship. Soc Sci Med. 2010;70:479-484.
7.
ShepherdSJParkerFCMuirJGGibsonPR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol. 2008;6:765-771.
8.
SilkDBDavisAVulevicJTzortzisGGibsonGR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29:508-501.
9.
PaineauDPayenFPanserieuS. The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders. Br J Nutr. 2008;99:311-318.
10.
OlesenMGudmand-HøyerE. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr. 2000;72:1570-1575.
11.
BarrettJSGibsonPR. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?Therap Adv Gastroenterol. 2012;5:261-268.
12.
GibsonPRShepherdSJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol. 2012;107:657-666.
13.
RothmanKGreenlandSLashT. Validity in epidemiologic studies. In: RothmanKGreenlandSLashT, eds. Modern Epidemiology. 3rd ed.Philadelphia, PA: Lippincott, Williams, and Wilkins; 2012.
14.
GasbarriniACorazzaGRGasbarriniG. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009;29(suppl 1):1-49.
